Vestal Point Capital as of June 30, 2025
Portfolio Holdings for Vestal Point Capital
Vestal Point Capital holds 72 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 9.5 | $181M | 2.8M | 65.85 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 6.7 | $127M | 1.2M | 106.12 | |
| Cytokinetics Com New (CYTK) | 5.2 | $98M | 3.0M | 33.04 | |
| Nuvalent Inc-a (NUVL) | 4.3 | $82M | 1.1M | 76.30 | |
| Vera Therapeutics Cl A (VERA) | 3.8 | $73M | 3.1M | 23.56 | |
| Amicus Therapeutics (FOLD) | 3.6 | $68M | 12M | 5.73 | |
| Xenon Pharmaceuticals (XENE) | 3.3 | $63M | 2.0M | 31.30 | |
| Dianthus Therapeutics (DNTH) | 3.1 | $60M | 3.2M | 18.63 | |
| Scholar Rock Hldg Corp (SRRK) | 2.8 | $53M | 1.5M | 35.42 | |
| Kalvista Pharmaceuticals (KALV) | 2.8 | $53M | 4.7M | 11.30 | |
| GE HealthCare Technologies Common Stock (GEHC) | 2.7 | $52M | 700k | 74.07 | |
| uniQure NV SHS (QURE) | 2.7 | $52M | 3.7M | 13.94 | |
| Bicara Therapeutics (BCAX) | 2.4 | $47M | 5.0M | 9.29 | |
| Alcon Ord Shs (ALC) | 2.4 | $46M | 525k | 88.28 | |
| Revolution Medicines (RVMD) | 2.3 | $44M | 1.2M | 36.79 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.3 | $43M | 1.5M | 28.76 | |
| EXACT Sciences Corporation (EXAS) | 2.0 | $37M | 700k | 53.14 | |
| Celldex Therapeutics Com New (CLDX) | 1.9 | $36M | 1.8M | 20.35 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 1.8 | $35M | 200k | 172.60 | |
| Immatics NV SHS (IMTX) | 1.8 | $34M | 6.3M | 5.38 | |
| Geron Corporation (GERN) | 1.8 | $34M | 24M | 1.41 | |
| Globus Medical Cl A (GMED) | 1.6 | $30M | 500k | 59.02 | |
| BioMarin Pharmaceutical (BMRN) | 1.4 | $28M | 500k | 54.97 | |
| MoonLake Immunotherapeutics Class A Ord (MLTX) | 1.4 | $26M | 550k | 47.20 | |
| Tyra Biosciences (TYRA) | 1.3 | $25M | 2.7M | 9.57 | |
| Savara (SVRA) | 1.3 | $25M | 11M | 2.28 | |
| Cooper Cos (COO) | 1.3 | $25M | 350k | 71.16 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.3 | $25M | 1.2M | 20.74 | |
| Cidara Therapeutics Com New (CDTX) | 1.3 | $24M | 500k | 48.71 | |
| Astria Therapeutics (ATXS) | 1.3 | $24M | 4.5M | 5.36 | |
| Abbott Laboratories (ABT) | 1.3 | $24M | 175k | 136.01 | |
| Edwards Lifesciences (EW) | 1.2 | $24M | 300k | 78.21 | |
| Nurix Therapeutics (NRIX) | 1.2 | $23M | 2.0M | 11.39 | |
| Cogent Biosciences (COGT) | 1.2 | $22M | 3.1M | 7.18 | |
| Bruker Corporation (BRKR) | 1.1 | $21M | 500k | 41.20 | |
| Ionis Pharmaceuticals (IONS) | 1.0 | $20M | 500k | 39.51 | |
| Day One Biopharmaceuticals I (DAWN) | 1.0 | $20M | 3.0M | 6.50 | |
| Medtronic SHS (MDT) | 0.9 | $17M | 195k | 87.17 | |
| Perrigo SHS (PRGO) | 0.9 | $17M | 625k | 26.72 | |
| Zymeworks Del (ZYME) | 0.8 | $14M | 1.2M | 12.55 | |
| Black Diamond Therapeutics (BDTX) | 0.7 | $14M | 5.6M | 2.48 | |
| Lexeo Therapeutics (LXEO) | 0.7 | $13M | 3.2M | 4.02 | |
| Nyxoah SA SHS (NYXH) | 0.6 | $11M | 1.4M | 7.48 | |
| Thermo Fisher Scientific (TMO) | 0.5 | $10M | 25k | 405.46 | |
| Danaher Corporation (DHR) | 0.5 | $9.9M | 50k | 197.54 | |
| Beta Bionics (BBNX) | 0.4 | $8.0M | 550k | 14.56 | |
| Disc Medicine (IRON) | 0.4 | $7.4M | 140k | 52.96 | |
| Solid Biosciences Com New (SLDB) | 0.4 | $7.3M | 1.5M | 4.87 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.4 | $6.9M | 3.0M | 2.31 | |
| Dyne Therapeutics (DYN) | 0.4 | $6.9M | 728k | 9.52 | |
| Travere Therapeutics (TVTX) | 0.3 | $5.3M | 355k | 14.80 | |
| Enliven Therapeutics (ELVN) | 0.3 | $5.0M | 250k | 20.06 | |
| Voyager Therapeutics (VYGR) | 0.2 | $4.6M | 1.5M | 3.11 | |
| Zimmer Holdings (ZBH) | 0.2 | $4.6M | 50k | 91.21 | |
| Becton, Dickinson and (BDX) | 0.2 | $4.3M | 25k | 172.25 | |
| Ventyx Biosciences (VTYX) | 0.2 | $4.3M | 2.0M | 2.14 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.2 | $4.1M | 50k | 81.86 | |
| Neurocrine Biosciences (NBIX) | 0.2 | $3.8M | 30k | 125.69 | |
| Applied Therapeutics (APLT) | 0.2 | $3.6M | 12M | 0.31 | |
| Fate Therapeutics (FATE) | 0.1 | $2.8M | 2.5M | 1.12 | |
| Passage Bio | 0.1 | $2.4M | 6.1M | 0.40 | |
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $2.1M | 950k | 2.20 | |
| Sutro Biopharma (STRO) | 0.1 | $1.9M | 2.6M | 0.71 | |
| OnKure Therapeutics Com Cl A (OKUR) | 0.1 | $1.5M | 635k | 2.39 | |
| Miragen Therapeutics (VRDN) | 0.1 | $1.4M | 100k | 13.98 | |
| Alector (ALEC) | 0.1 | $1.4M | 977k | 1.40 | |
| Engene Holdings (ENGN) | 0.1 | $1.3M | 370k | 3.64 | |
| Arcutis Biotherapeutics (ARQT) | 0.1 | $1.3M | 95k | 14.02 | |
| Atara Biotherapeutics Com New (ATRA) | 0.0 | $726k | 94k | 7.72 | |
| Macrogenics (MGNX) | 0.0 | $339k | 280k | 1.21 | |
| Tenax Therapeutics Com New (TENX) | 0.0 | $308k | 53k | 5.76 | |
| Traws Pharma Com New (TRAW) | 0.0 | $222k | 150k | 1.48 |